Zimbabwe has rejected a major US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years over the United States' demand for confidential biological samples.
This move was revealed after a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".
A government spokesman later clarified that the US was seeking genetic material for research and commercial purposes but was unwilling to guarantee the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for more talks to reach a deal agreeable to both sides so the country's vital HIV programme can proceed.
Wider Context
This rejection follows a comparable situation in Kenya, where a court suspended a similar deal with the US after legal challenges were raised about the safety of citizens' health data.
Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
The agency had managed aid for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance openness and responsibility.
Based on reports, 16 African countries have so far agreed to these new agreements, constituting over $18.3bn of fresh investment.
Details of the Rejected Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported initiatives," Tremont said.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no equivalent assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that shared data," he stated.
"Put simply, our country would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our people should a new pandemic emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its push of one-on-one health agreements were disrupting systems previously set up through the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to deal with potential pandemics.
"This mechanism is designed to guarantee that when a country contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome further dialogue with our US partners on how future co-operation could be arranged in a manner that honours the independence and interests of both nations."
Medical Community Reaction
A leading public health body stated it recognised the official position, but suggested that talks need to persist considering a large portion of the nation's HIV programmes relied on external financing.
"In cases where specific concerns arise, including those relating to data governance or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," the group added.
The situation highlights the ongoing challenges between accepting vital international aid and safeguarding a country's data in an ever more interconnected world.